BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 20413767)

  • 21. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx.
    Chen YK; Su CT; Chi KH; Cheng RH; Wang SC; Hsu CH
    J Nucl Med; 2007 Jan; 48(1):8-14. PubMed ID: 17204693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT texture analysis of tonsil cancer: Discrimination from normal palatine tonsils.
    Kim TY; Lee JY; Lee YJ; Park DW; Tae K; Choi YY
    PLoS One; 2021; 16(8):e0255835. PubMed ID: 34379652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
    Brady MJ; Thomas J; Wong TZ; Franklin KM; Ho LM; Paulson EK
    Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage.
    Dong X; Xing L; Wu P; Fu Z; Wan H; Li D; Yin Y; Sun X; Yu J
    Nucl Med Commun; 2013 Jan; 34(1):40-6. PubMed ID: 23111378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
    Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
    J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.
    Noda Y; Kanematsu M; Goshima S; Suzui N; Hirose Y; Matsunaga K; Nishibori H; Kondo H; Watanabe H; Kawada H; Kawai N; Tanahashi Y; Bae KT
    Eur Radiol; 2015 Oct; 25(10):3009-16. PubMed ID: 25854217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
    Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Coleman RE
    Radiology; 2007 Jul; 244(1):263-72. PubMed ID: 17495174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidental head and neck (18)F-FDG uptake on PET/CT without corresponding morphological lesion: early predictor of cancer development?
    Heusner TA; Hahn S; Hamami ME; Kögel S; Forsting M; Bockisch A; Antoch G; Stahl AR
    Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1397-406. PubMed ID: 19305995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters.
    Hadiprodjo D; Ryan T; Truong MT; Mercier G; Subramaniam RM
    AJR Am J Roentgenol; 2012 Feb; 198(2):W185-90. PubMed ID: 22268210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.
    Kidd EA; Dehdashti F; Siegel BA; Grigsby PW
    Radiother Oncol; 2010 Jun; 95(3):288-91. PubMed ID: 20231040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
    Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
    J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.
    Kwee SA; Ko JP; Jiang CS; Watters MR; Coel MN
    Radiology; 2007 Aug; 244(2):557-65. PubMed ID: 17581887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
    Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH
    Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of contrast medium enhancement and [(18)F]-FDG uptake of liver metastasis in PET/CT prior to therapy.
    Hundt W; la Fougère C; Vogtmann J; Steinbach S; Burbelko M; Tiling R
    Eur J Radiol; 2012 Apr; 81(4):652-7. PubMed ID: 21300504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.